Connect with us


President Preps Executive Order That Would Put America at Front of Vaccine Line


While the coronavirus crisis appears to be on a track to royally ruining our Christmas plans, there is some good news way out on the horizon.

There are several pharmaceutical companies that have now completed testing of their own COVID-19 vaccines, several of whom have reported success rates in the 94%-95% range.  Typically, a vaccine is considered effective at ~50%, making these truly promising developments.

Of course, this isn’t going to be an overnight fix.  The inoculation will take months to occur, as the medicine itself needs to be manufactured en masse, and then distributed in an appropriately weighted manner.

Trending: Colorado Business Now Requiring Proof of Vaccine for Entry

President Trump, concerned about how quickly these vaccines could find their way into the American population, is now preparing an executive action that could guarantee that we the people end up at the front of the line.

take our poll - story continues below

Is the Biden Administration Destroying Our Constitution?

  • Is the Biden Administration Destroying Our Constitution?  

  • This field is for validation purposes and should be left unchanged.
Completing this poll grants you access to Liberty Hub updates free of charge. You may opt out at anytime. You also agree to this site's Privacy Policy and Terms of Use.

President Trump is expected to sign an executive order Tuesday that will ensure all Americans have access to the coronavirus vaccine before the U.S. government begins aiding nations around the world, Fox News has learned.

Senior administration officials told Fox News Monday that the president will reemphasize to the American people that the “priority has been an America First approach,” during a vaccine summit at the White House Tuesday.

The news of the executive order comes just days ahead of the Food and Drug Administration’s Thursday meeting regarding Pfizer and BioNTech’s application for emergency authorization of their coronavirus vaccine, three weeks after the companies filed for it. The FDA also plans to meet on Dec. 17 to discuss Moderna’s vaccine.

A source close to the White House Coronavirus Task Force told Fox News last week that the Pfizer-BioNTech authorization could come as early as Friday. FDA Commissioner Stephen Hahn last week said that they are “very hopeful” of approval and that they are “moving very quickly.”

“The priority is to make sure we distribute these vaccines to Americans before we start shipping them around the world to get international access,” an official told Fox News, predicting that international assistance could come “late spring, early summer,” and after they “achieve vaccinating those who have a desire to be vaccinated.”

Now the only problem will be getting Americans to take the vaccine.

Recent studies have shown that only about 60% of Americans are willing to received the vaccine at this time.  Experts warn that, in order for the vaccine to be effective on a nation scale, at least 70% of the population would need to receive it.  Otherwise, the disease can continue to fester and mutate in the wild, decreasing the efficacy of the vaccine.


Save conservative media!

Become an insider!

Sign up for our free email newsletter, and we'll make sure to keep you in the loop.

You Might Like

Join the conversation!

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it, please mark it as spam. Thank you for partnering with us to maintain fruitful conversation.

You Might Like

Let’s STOP the Washington Power Grab | Schaftlein Report


Biden Set to Officially Examine Possibility of Packing Supreme Court


Arizona Goes on The Offensive, Blocking Biden Gun Orders Via Legislation


MUST SEE: Explosive Eruption Rocks Caribbean Paradise as Evacuations Continue